![](https://investorshub.advfn.com/uicon/442430.png?cb=1539603792)
Tuesday, February 03, 2015 9:33:45 PM
This is a "Q3 2014 Earnings and Operating Results Conference Call November 12, 2014 @ 4:15 pm Eastern" From a OTC stock that recently uplisted.
The Documentation shows that the day prior to the conference call they initiated the uplisting application to NASDAQ.
http://www.cytosorbents.com/pdf/CytoSorbents_Q3_2014_Transcript.pdf
About a month later they initiated a 25:1 reverse split, and within a few weeks Dec 23, they announced they were uplisting.
I think the conference call is an awesome read, skip to the parts that relate to the "Reasons for uplisting", specifically, "why now". Then check out all the explanation of the reverse split and why it is the right course of action.
Lastly, if you look at this companies SEC submissions, looks like a large exclusive deal was put out in an 8K right after the RS took effect. So all this great news surrounded the uplisting.
Note, this is their, "Q3" transcript for period ending Aug 30th. If we did this according to our own "New Q3", we would potentially submit the formal application in May, for a July Uplisting....
Hope we follow these footsteps!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM